More Life Sciences Articles
M&A Surges as Strategic Buyers Seek Next Big Thing in Life Sciences
Clifford Chance’s Benjamin Sibbett and Daryl Fairbairn discuss the nature of M&A in the industry—today and tomorrow.
CCBJ: What are the market trends in the life sciences M&A space?
Daryl Fairbairn: Most M&A in the life sciences sector is executed by strategic buyers...Read More
Joys and Challenges of IP Practice at the Intersection of Science and Business
Burns & Levinson’s Dr. Daniel W. Clarke, Dr. Christopher Cowles and Dr. Richard Emmons talk about their experiences representing life sciences clients.
CCBJ: Tell us about your background and your practice.
Dr. Daniel Clarke: I earned my Ph.D. in molecular microbiology before becoming a...Read More
Changes in the Law Leave Life Sciences Litigators Dancing as Fast as They Can: Lawyers also await guidance from the FDA
Steven Maslowski, an IP litigator at Akin Gump Strauss Hauer & Feld LLP, handles cases on the cutting edge of life sciences. It’s a complicated place to be these days, as the courts are sorting through changes in the law and litigators are waiting for guidance from the Food and Drug...Read More